Compound

Achira, a biotechnology company, specializes in accelerating drug discovery by combining artificial intelligence and physics-based simulations. It develops high-fidelity, scalable models for molecular dynamics, generating synthetic data to enhance drug discovery processes. By addressing the scarcity and high cost of drug discovery data, Achira's atomistic foundation simulation models enable clients to identify and develop therapeutic compounds more efficiently.

AI.Reverie, Inc. is a company that specializes in developing a simulation platform designed to generate synthetic data and simulations for businesses. Founded in 2016 and based in San Jose, California, the platform assists organizations in training their machine learning algorithms and enhancing their artificial intelligence applications. AI.Reverie's offerings include a suite of synthetic data and vision APIs that enable clients to create customized virtual environments. This technology supports various industries by facilitating the development of smart cities, sustainable farms, and safer homes. Through its innovative approach, AI.Reverie aims to improve the efficiency and effectiveness of AI solutions across diverse applications.

AI.Reverie, Inc. is a company that specializes in developing a simulation platform designed to generate synthetic data and simulations for businesses. Founded in 2016 and based in San Jose, California, the platform assists organizations in training their machine learning algorithms and enhancing their artificial intelligence applications. AI.Reverie's offerings include a suite of synthetic data and vision APIs that enable clients to create customized virtual environments. This technology supports various industries by facilitating the development of smart cities, sustainable farms, and safer homes. Through its innovative approach, AI.Reverie aims to improve the efficiency and effectiveness of AI solutions across diverse applications.